Physician profile
Grae L Schuster
NPI 1831137751
$1,051.53
in general payments reported to CMS, 2019-2025
12 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.23 · 2020: $84.95 · 2021: $14.70 · 2022: $75.12 · 2023: $121 · 2024: $313 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $499.95 | 2023-2025 | Enhertu |
| Sumitomo Pharma America, INC. | $235.25 | 2023-2025 | Orgovyx |
| Janssen Biotech, INC. | $84.95 | 2020 | |
| Tactile Systems Technology INC | $72.86 | 2021-2022 | |
| Accuray Incorporated | $30.34 | 2024 | |
| Progenics Pharmaceuticals, INC. | $24.91 | 2023 | Pylarify |
| Verity Pharmaceuticals INC. | $24.44 | 2025 | Trelstar |
| Merck Sharp & Dohme LLC | $20.64 | 2024 | Keytruda |
| Myovant Sciences INC. | $16.96 | 2022 | |
| Fortovia Therapeutics, INC. | $15.24 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grae Schuster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.